Transforming growth factor-β1 (TGF-β1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation

American Journal of Hypertension

Volumn 17, Issue 4, 2004, Pages 334-338

  Muy Rivera, Martin ^a   Sanchez, Sixto E ^b   Vadachkoria, Surab ^a   Qiu, Chunfang ^a   Bazul, Victor ^c   Williams, Michelle A ^a,d  

^a SWEDISH MEDICAL CENTER   (United States)

^b HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^c Materno Perinatal Institute   (Peru)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cytokines; Peru; Preeclampsia; Pregnancy; Soluble receptors; Transforming growth factor 1, tumor necrosis factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADOLESCENT; ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MATERNAL AGE; MATERNAL WELFARE; PERU; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS; STATISTICS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 1842614365     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.12.010     Document Type: Article

References (15)

1. Topper JN: TGF-β in the cardiovascular system: molecular mechanisms of context-specific growth factor. Trends Cardiovasc Med 2000;10:132-137
2. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results on multifocial inflammatory disease. Nature. 359:1992;693-699.
3. Roberts A.M., Sporn M.B. Transforming growth factor. Adv Cancer Res. 51:1988;107-145.
4. August P., Leventhal B., Suthanthiran M. Hypertension-induced organ damage in African Americans transforming growth factor-β1 excess as a mechanism for increased prevalence. Curr Hyper Reports. 2:2000;184-191.
5. Li B., Khana A., Sharma V., Singh T., Suthanthiran M., August P. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension. 33:1999;271-275.
6. Ando N., Hirahara F., Fukushima J., Kawamoto S., Okuda K., Funabashi T., Gorai I., Minaguchi H. Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy and at the human maternal-fetal interface. Am J Reprod Immunol. 40:1998;48-56.
7. Djurovic S., Schjetlein R., Wilsoff F., Haugen G., Husby H., Berg K. Plasma concentrations of Lp(a) lipoprotein and TGF-β1 are altered in preeclampsia. Clin Genet. 52:1997;371-376.
8. Benian A., Madazli R., Aksu F., Uzun H., Aydin S. Plasma and placenta levels of interleukin-10, transforming factor-β1 and epithelial cadherin in preeclampsia. Obstet Gynecol. 100:2002;327-331.
9. Naicker T., Khedun S.M., Noodley J. Transforming growth factor β1 levels in platelet depleted plasma in African women with preeclampsia. J Obstet Gynaec. 22:2002;279-282.
10. Hennessy A., Orange S., Willis N., Painter D.M., Child A., Horvath J.S. Transforming growth factor-β1 does not relate to hypertension in pre-eclampsia. Clin Exper Pharmacol Physiol. 29:2002;968-971.
11. Clausen T, Djurovic S, Reseland JE, Berg K, Drevon CA, Henriksen T: Altered plasma concentrations of leptin, transforming growth factor-β1 and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 1002;23:380-385
12. Huber A., Hefler L., Tempfer C., Zeislar H., Lebrecht A., Husslein P. Transforming growth factor β1 serum levels in pregnancy and preeclampsia. Acta Obstet Gynecol Scand. 81:2002;168-171.
13. Sanchez S.E., Zhang C., Williams M.A., Ware-Jauregui S., Larrabure G., Bazul V., Farrand A. Tumor necrosis factor-α soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. J Reprod Immunol. 47:2000;49-63.
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 183:2000;S1-S22.
15. Morrish D.W., Bhardwaj D., Paras M.T. Transforming growth factor beta 1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology. 129:1991;22-26.